RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

NCT02991807 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

PTEN Gene Mutation
PTEN Hamartoma Tumor Syndrome

Interventions

DRUG: RAD001
DRUG: Placebo

Sponsor

Boston Children's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]